Switch to:
More From Other Websites
[$$] Teva, Allergan Pump Up the Pipelines Sep 22 2016
Regeneron, Teva Collaborate to Develop Chronic Pain Drug Sep 21 2016
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug Sep 21 2016
Regeneron to Collaborate With Teva for Fasinumab Drug (REGN, TEVA) Sep 20 2016
Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 20 2016
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
RBC Says These 4 Top Biotechs Could Have Big Upside Potential Sep 19 2016
5 Trade Ideas for Monday: TD Ameritrade, AstraZeneca, Costco, International Paper and Regeneron Sep 18 2016
Vertex: Did Management Deliver Investors a Backhanded Slap? Sep 16 2016
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 14 2016
Regeneron Pharmaceuticals, Inc. – Value Analysis (NASDAQ:REGN) : September 13, 2016 Sep 13 2016
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors Sep 12 2016
Regeneron Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : REGN-US :... Sep 12 2016
Regeneron’s Growth Opportunities: Praluent, Sarilumab, and Dupilumab Sep 01 2016
Regeneron Announces Upcoming 2016 Investor Conference Presentations Sep 01 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK